Salivary IL-1β and PGE2 as biomarkers of periodontal status, before and after periodontal treatment.
about
Interleukin 1β-A Potential Salivary Biomarker for Cancer Progression?Salivary biomarkers associated with gingivitis and response to therapyInflammatory cytokine levels in patients with periodontitis and/or coronary heart disease.Salivary Visfatin Concentration in Response to Non-surgical Periodontal Therapy.Essential and Toxic Metals in Oral Fluid-a Potential Role in the Diagnosis of Periodontal DiseasesHost-derived salivary biomarkers in diagnosing periodontal disease: systematic review and meta-analysis.Regulation of inflammation by lipid mediators in oral diseases.Periodontal Therapy Effects on Nitrite Related to Oral Bacteria: A 6-Month Randomized Clinical Trial.Association between low-dose aspirin and periodontal disease: results from the continuous national health and nutrition examination survey (NHANES) 2011-2012.Parameters of oxidative stress in saliva from patients with aggressive and chronic periodontitis.Gingival Tissue Inflammation Promotes Increased Matrix Metalloproteinase-12 Production by CD200Rlow Monocyte-Derived Cells in Periodontitis.Persistence of Porphyromonas gingivalis is a negative predictor in patients with moderate to severe periodontitis after nonsurgical periodontal therapy.Salivary Levels of NLRP3 Inflammasome-Related Proteins as Potential Biomarkers of Periodontal Clinical Status.A Review of Evidence for a Therapeutic Application of Traditional Japanese Kampo Medicine for Oral Diseases/Disorders.Effects of Kangfuxin solution on IL-1β, IL-6, IL-17 and TNF-α in gingival crevicular fluid in patients with fixed orthodontic gingivitis.Change of scaling-induced proinflammatory cytokine on the clinical efficacy of periodontitis treatment
P2860
Q26798564-8C565EE3-5F48-46B8-8754-E14FF2E2D965Q35324443-C9373070-9C6C-40F7-A5D3-4C9C297DB5B2Q35406921-F6573AE5-FED0-4DFA-B9AD-45783C03ACCEQ35622901-B40CB7C2-6ECF-468F-98D7-79E22C26E701Q37245914-80BE05A8-AFD5-4EF3-A86F-3FB58C483778Q38754708-F2F060D3-1BFA-489C-8A38-06E0B69DEA75Q38899898-1DD90964-B150-4B46-94F0-9B5DF49035F1Q41155667-E60CF512-E66F-4081-A193-DCEAA5577A57Q41434526-A2A5B37F-C792-46AF-9F48-6FBADD9FC3A5Q46530316-C5929752-3457-4B78-9C30-D2DDED75DD80Q47442881-38040A0C-1A8C-423E-BD72-9B24C5D37F97Q48096994-E502E7D3-4E6F-435C-9F63-7148C7F2F231Q50900027-FE4CBDC0-CAD7-45CB-BCD7-A53497922659Q52316719-CDEEDDE3-2F7C-4EC6-A262-EAC39BD980BBQ55312281-E82FAB79-413A-40E8-876F-AAA0CB288440Q59121163-2C0EC7FA-380E-4C0D-B46C-C2702856E71E
P2860
Salivary IL-1β and PGE2 as biomarkers of periodontal status, before and after periodontal treatment.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Salivary IL-1β and PGE2 as bio ...... d after periodontal treatment.
@en
Salivary IL-1β and PGE2 as bio ...... d after periodontal treatment.
@nl
type
label
Salivary IL-1β and PGE2 as bio ...... d after periodontal treatment.
@en
Salivary IL-1β and PGE2 as bio ...... d after periodontal treatment.
@nl
prefLabel
Salivary IL-1β and PGE2 as bio ...... d after periodontal treatment.
@en
Salivary IL-1β and PGE2 as bio ...... d after periodontal treatment.
@nl
P2093
P2860
P356
P1476
Salivary IL-1β and PGE2 as bio ...... d after periodontal treatment.
@en
P2093
Alejandra Delgado
Gabriel A Sánchez
Lucila Busch
Valeria A Miozza
P2860
P304
P356
10.1111/JCPE.12164
P407
P577
2013-10-01T00:00:00Z